| Financial Year |
March 31 2023 |
| Monetary Funds |
565,303,866.92 |
| Held-for-trading Financial Assets |
641,033,627.15 |
| Notes Receivable |
24,243,225.55 |
| Accounts Receivable |
963,037,725.25 |
| Advances to Suppliers |
2,959,526.59 |
| Other Receivables |
23,489,493.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
281,359,010.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,378,121.78 |
| Total Current Assets |
2,533,363,503.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,617,804,030.51 |
| Under-construction Projects |
1,126,226.54 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,308,980.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,966,236.59 |
| Deferred Income Tax Assets |
30,061,261.75 |
| Other Non-Current Assets |
18,619,641.07 |
| Sub-Total of Non-Current Assets |
2,569,550,210.48 |
| Total Assets |
5,102,913,714.03 |
| Short-Term Loans |
253,240,109.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
282,207,981.57 |
| Accounts Payable |
640,029,520.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
79,523,127.97 |
| Taxes Payable |
9,826,465.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
60,852,716.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
4,183,652.50 |
| Sub-Total of Current Liabilities |
1,366,391,867.03 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
13,637,774.99 |
| Deferred Income Tax Liabilities |
14,809,927.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
85,987,177.93 |
| Total Liabilities |
1,452,379,044.96 |
| Paid-In Capital(Or Share Stock) |
998,442,611.00 |
| Capital Surplus |
1,018,976,375.03 |
| Surplus Reserve |
465,615,054.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,158,999,927.43 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,650,534,669.07 |
| Owner's Equity（Stockholder's Equity） |
3,650,534,669.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,102,913,714.03 |
